ArticleJournal of proteome research2026
Evaluation of Data-Independent Acquisition-Based Phosphoproteomics Analysis in Mammalian and Bacterial Systems.
Article in Journal of proteome research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent advancements in data-independent acquisition (DIA) workflows have greatly increased the depth and throughput of mass spectrometry-based proteomics. However, many of these advancements remain undercharacterized for phosphoproteomics, particularly in bacteria that have fewer protein phosphorylation events. We evaluated the impact of instrument/gradient length (Orbitrap Astral, 15 min; Orbitrap Exploris, 90 min), analysis tools (DIA-NN 1.9.2, DIA-NN 2.3, FragPipe, Spectronaut), and library search strategies (spectral-library versus library-free) on phosphoproteomic coverage and quantification in a human cell line and bacterial lysate. The 15 min Astral analysis identified similar numbers of phosphopeptides compared to a 90 min Exploris acquisition method across all analysis tools, demonstrating a substantial advantage in throughput. Within the Astral workflow, Spectronaut provided the highest phosphoproteome coverage, whereas DIA-NN 1.9.2, DIA-NN 2.3, and FragPipe exhibited less quantitative variation. We compared library-free and spectral-library search strategies using the
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.